Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 8/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12901808 | 0.86 | ALDH1A1 (0.41) | LIMK1ALDH1A1 | |
| SCHEMBL12901806 | 0.86 | ALDH1A1 (0.41) | LIMK1ALDH1A1 | |
| SCHEMBL3130541 | 0.82 | ALDH1A1 (0.42) | PIM1PIM2ESR1ESR2ALDH1A1 | |
| SCHEMBL12887181 | 0.81 | PTGES (0.37) | LIMK1ALDH1A1MAPT | |
| SCHEMBL9976848 | 0.78 | ESR1 (0.47) | LIMK1ESR1ESR2ALDH1A1MAPT | |
| SCHEMBL23556042 | 0.76 | MAPT (0.43) | LIMK1ESR1ESR2ALDH1A1MAPT | |
| SCHEMBL18470268 | 0.76 | ESR1 (0.50) | LIMK1ESR1ESR2ALDH1A1MAPT | |
| SCHEMBL18470273 | 0.75 | ESR1 (0.44) | LIMK1ESR1ESR2ALDH1A1MAPT | |
| SCHEMBL23555971 | 0.75 | LIMK1 (0.43) | LIMK1ESR1ESR2ALDH1A1MAPT | |
| SCHEMBL12887191 | 0.75 | LIMK1 (0.35) | LIMK1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110040107-A1 | [1]BENZOTHIENO[3,2-B][1]BENZOTHIOPHENE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
| WO-2009128559-A1 | [1]BENZOTHIENO[3,2-B][1]BENZOTHIOPHENE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2009-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110040107-A1 | [1]BENZOTHIENO[3,2-B][1]BENZOTHIOPHENE COMPOUND AND METHOD FOR PRODUCING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | KYAT1, SULT1E1, SULT1A1 | PIM1 1339/4885PIM2 1710/4885LIMK1 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.